000 | 01846 a2200553 4500 | ||
---|---|---|---|
005 | 20250515223830.0 | ||
264 | 0 | _c20101007 | |
008 | 201010s 0 0 eng d | ||
022 | _a1471-2431 | ||
024 | 7 |
_a10.1186/1471-2431-10-33 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWamalwa, Dalton C | |
245 | 0 | 0 |
_aPredictors of mortality in HIV-1 infected children on antiretroviral therapy in Kenya: a prospective cohort. _h[electronic resource] |
260 |
_bBMC pediatrics _cMay 2010 |
||
300 |
_a33 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAnti-HIV Agents _xtherapeutic use |
650 | 0 | 4 |
_aAntiretroviral Therapy, Highly Active _xmethods |
650 | 0 | 4 |
_aBody Height _xdrug effects |
650 | 0 | 4 | _aBody Mass Index |
650 | 0 | 4 |
_aBody Weight _xdrug effects |
650 | 0 | 4 | _aCD4 Lymphocyte Count |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
650 | 0 | 4 |
_aHIV-1 _xdrug effects |
650 | 0 | 4 |
_aHemoglobins _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfant |
650 | 0 | 4 |
_aKenya _xepidemiology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aProportional Hazards Models |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aViral Load _xdrug effects |
700 | 1 | _aObimbo, Elizabeth M | |
700 | 1 | _aFarquhar, Carey | |
700 | 1 | _aRichardson, Barbra A | |
700 | 1 | _aMbori-Ngacha, Dorothy A | |
700 | 1 | _aInwani, Irene | |
700 | 1 | _aBenki-Nugent, Sara | |
700 | 1 | _aJohn-Stewart, Grace | |
773 | 0 |
_tBMC pediatrics _gvol. 10 _gp. 33 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1186/1471-2431-10-33 _zAvailable from publisher's website |
999 |
_c19836612 _d19836612 |